Cargando…

The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and $^{225}$Ac in tumor bearing mice

Detalles Bibliográficos
Autores principales:	Beyer, Gerd-Jürgen, Offord, Robin E, Künzi, G, Aleksandrova, Y, Ravn, U, Jahn, S, Barker, J, Tengblad, O, Lindroos, M
Lenguaje:	eng
Publicado:	1996
Materias:	Health Physics and Radiation Effects
Acceso en línea:	https://dx.doi.org/10.1016/S0969-8051(97)80001-7 http://cds.cern.ch/record/318845

Ejemplares similares

Use of radioactive ion beams for biomedical research: 1. in vivo labeling of monoclonal antibodies with radio-lanthanides and $^{225}$Ac
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1993)

Comparison of the biodistribution of $^{225}$Ac and radiolanthanides as citrate complexes
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1990)

Simultaner Vergleich der Bioverteilung von $^{87}$Y-Citrat and $^{88}$Y-EDTMP tumortragenden Ratten
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1991)

Use of Radioactive Ion Beams for Biomedical Research 1. in vivo labelling of monoclonal antibodies with radio-lanthanides and $^{225}$Ac
Publicado: (2002)

Biodistribution and dosimetry for combined [(177)Lu]Lu-PSMA-I&T/[(225)Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
por: Delker, Astrid, et al.
Publicado: (2023)

Nuclear medicine: radio-isotopes, production and application
por: Beyer, Gerd-Jürgen
Publicado: (1999)

Absorbed dose assessment of (177)Lu-zoledronate and (177)Lu-EDTMP for human based on biodistribution data in rats
por: Yousefnia, Hassan, et al.
Publicado: (2015)

[(225)Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer: Preclinical Evaluation and Comparison with [(225)Ac]Ac-PSMA-617
por: Busslinger, Sarah D., et al.
Publicado: (2022)

Synthesis and Stability of Actinium-225 Endohedral Fullerenes, (225)Ac@C(60)
por: Mwakisege, Jofa Gideon, et al.
Publicado: (2020)

New measurement of exotic decay of $^{225}$Ac by $^{14}$C emission
por: Guglielmetti, A, et al.
Publicado: (2001)

Nuclear structure effects in the exotic decay of $^{225}$Ac via $^{14}$C emission
por: Bonetti, R, et al.
Publicado: (1993)

Synthesis and Ready to Use Kit Formulation of EDTMP for the Preparation of 177Lu-EDTMP as a Bone Palliation Radiopharmaceutical
por: Mercanoglu, Guldem, et al.
Publicado: (2023)

Towards Alpha Dosimetry with Laser Ionized and Mass Separated 225Ac: Setup Development and Source Characterization
por: Van den Bergh, Viktor
Publicado: (2022)

Solid-phase extraction of $^{225}$Ac using ion-imprinted resin and $^{243}$Am as a radioactive tracer for internal dosimetry and incorporation measurements
por: Cusnir, Ruslan, et al.
Publicado: (2022)

sup 8 sup 9 Sr and sup 1 sup 5 sup 3 Sm-EDTMP therapy of disseminated skeletal metastasis
por: Zhang Jun Ning, et al.
Publicado: (2001)

Nuclear structure effects in the exotic decay of $^{225}$Ac via $^{14}$C emission
por: Bonetti, R, et al.
Publicado: (1992)

Resonant laser ionization and mass separation of $^{225}$Ac
por: Johnson, Jake D, et al.
Publicado: (2023)

The application of poorly crystalline silicotitanate in production of (225)Ac
por: Fitzsimmons, Jonathan, et al.
Publicado: (2019)

Development of (225)Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences
por: Robertson, Andrew Kyle Henderson, et al.
Publicado: (2018)

Resonant laser ionization and mass separation of (225)Ac
por: Johnson, Jake D., et al.
Publicado: (2023)

Estimating (225)Ac yield in thorium metal targets
por: Rahmani, M., et al.
Publicado: (2023)

Evaluation of Actinium-225 Labeled Minigastrin Analogue [(225)Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy
por: Qin, Yun, et al.
Publicado: (2020)

Implantation: ein neues Prinzip für einen $^{81}$Rb$^{81m}$Kr- Generator für in-vivo Anwendung
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1991)

Cure of Disseminated Human Lymphoma with [(225)Ac]Ac-Ofatumumab in a Preclinical Model
por: Longtine, Mark S., et al.
Publicado: (2023)

Beyond Palliation: Therapeutic Applications of (153)Samarium-EDTMP
por: Wilky, Breelyn A., et al.
Publicado: (2013)

Targeted cancer therapy: the potential role of terbium-149
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1996)

A high-purity $^{82}$Sr/$^{82}$Rb generator
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1990)

A new type of $^{81}$Rb $^{81m}$Kr generator for medical use
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1984)

Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias.
por: Keeling, A. A., et al.
Publicado: (1989)

Treatment efficacy of (153)Sm-EDTMP for painful bone metastasis
por: Ayati, Narjess, et al.
Publicado: (2013)

Estimation of relative biological effectiveness of (225)Ac compared to (177)Lu during [(225)Ac]Ac-PSMA and [(177)Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRAS
por: Rumiantcev, Mikhail, et al.
Publicado: (2023)

Cyclotron production of (225)Ac from an electroplated (226)Ra target
por: Nagatsu, Kotaro, et al.
Publicado: (2021)

Ac-EAZY! Towards GMP-Compliant Module Syntheses of (225)Ac-Labeled Peptides for Clinical Application
por: Pretze, Marc, et al.
Publicado: (2021)

Comparative Therapeutic Efficacy of (153)Sm-EDTMP and (177)Lu-EDTMP for Bone Pain Palliation in Patients with Skeletal Metastases: Patients’ Pain Score Analysis and Personalized Dosimetry
por: Sharma, Sarika, et al.
Publicado: (2017)

α-Zirconium(IV) Phosphate: Static Study of (225)Ac Sorption in an Acidic Environment and Its Kinetic Sorption Study Using (nat)Eu as a Model System for (225)Ac
por: Ondrák, Lukáš, et al.
Publicado: (2023)

Towards reliable production of 225Ac for medical applications: Systematic analysis of the production of Fr, Ra and Ac beams.
por: Dockx, Kristof, et al.
Publicado: (2017)

Initial Findings on the Use of [(225)Ac]Ac-DOTATATE Therapy as a Theranostic Application in Patients with Neuroendocrine Tumors
por: Demirci, Emre, et al.
Publicado: (2023)

Spallation produced radioisotopes for nuclear medical application
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1989)

Development of (225)Ac Production from Low Isotopic Dilution (229)Th
por: Camacaro, Jose F., et al.
Publicado: (2023)

Signaling Network Response to α-Particle–Targeted Therapy with the (225)Ac-Labeled Minigastrin Analog (225)Ac-PP-F11N Reveals the Radiosensitizing Potential of Histone Deacetylase Inhibitors
por: Qin, Yun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nlblboq5i8g2onttos3jdqal2j